Correlation Between Lipocine and Udemy
Can any of the company-specific risk be diversified away by investing in both Lipocine and Udemy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Udemy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Udemy Inc, you can compare the effects of market volatilities on Lipocine and Udemy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Udemy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Udemy.
Diversification Opportunities for Lipocine and Udemy
Modest diversification
The 3 months correlation between Lipocine and Udemy is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Udemy Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Udemy Inc and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Udemy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Udemy Inc has no effect on the direction of Lipocine i.e., Lipocine and Udemy go up and down completely randomly.
Pair Corralation between Lipocine and Udemy
Given the investment horizon of 90 days Lipocine is expected to generate 2.04 times more return on investment than Udemy. However, Lipocine is 2.04 times more volatile than Udemy Inc. It trades about 0.02 of its potential returns per unit of risk. Udemy Inc is currently generating about -0.04 per unit of risk. If you would invest 492.00 in Lipocine on September 3, 2024 and sell it today you would lose (38.00) from holding Lipocine or give up 7.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipocine vs. Udemy Inc
Performance |
| Timeline |
| Lipocine |
| Udemy Inc |
Lipocine and Udemy Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipocine and Udemy
The main advantage of trading using opposite Lipocine and Udemy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Udemy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Udemy will offset losses from the drop in Udemy's long position.| Lipocine vs. DiaMedica Therapeutics | Lipocine vs. Lyra Therapeutics | Lipocine vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |